US2019209681A1PendingUtilityA1

Anti-LPS Enriched Immunoglobulin Preparation for Use in the Treatment and/or Prophylaxis of a Pathologic Disorder

41
Assignee: IMMURON LTDPriority: Apr 27, 2009Filed: Nov 2, 2018Published: Jul 11, 2019
Est. expiryApr 27, 2029(~2.8 yrs left)· nominal 20-yr term from priority
A61P 37/02A61P 3/08A61P 3/06A61P 7/00A61P 3/10A61P 9/12A61P 5/06A61P 37/04A61P 9/10A61P 25/00A61P 25/28A61P 3/04A61P 31/00A61K 39/39583C07K 16/04C07K 16/1232C07K 2317/12C07K 16/26A61K 2039/507A61K 39/39508A61K 2039/505A61P 11/06A61P 1/16A61P 1/18
41
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the use of preparations enriched with anti LPS antibodies, such as those derived from mammalian colostrum or avian eggs, and optionally further antibodies against disease-associated antigens, colostrums, milk or milk product component/s and any adjuvants for treating, delaying or preventing the progression of a pathologic disorder such as chronic liver disease, cirrhosis and any complication or disorder associated therewith. The invention further relates to combined compositions comprising a combination of anti-LPS enriched antibody preparations and antibodies recognizing at least one antigen specific for a pathologic disorder and uses thereof in the treatment of immune-related disorders.

Claims

exact text as granted — not AI-modified
1 .- 138 . (canceled) 
     
     
         139 . A method of treating a subject who has an inflammatory bowel disease, the method comprising:
 selecting a subject who has an inflammatory bowel disease; and   orally administering to the selected subject a therapeutically effective dose of an anti-LPS enriched immunoglobulin preparation derived from colostrum.   
     
     
         140 . The method of  claim 139 , wherein the subject has ulcerative colitis or Crohn's disease. 
     
     
         141 . The method of  claim 139 , wherein the anti-LPS immunoglobulin-enriched preparation is prepared by immunizing a cow with LPS comprising O6, O8, O15, O25, O27, O63, O78, O114, O115, O128, O148, O153, and O159. 
     
     
         142 . The method of  claim 139 , wherein the anti-LPS immunoglobulin-enriched preparation is administered at a dose of 100 mg to 2000 mg per day. 
     
     
         143 . The method of  claim 142 , wherein the anti-LPS immunoglobulin-enriched preparation is administered at a dose of 1800 mg per day. 
     
     
         144 . The method of  claim 139 , wherein the colostrum is bovine colostrum. 
     
     
         145 . The method of  claim 139 , wherein the colostrum is freeze-dried colostrum.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.